11202017Headline:

El Dorado, Arkansas

HomeArkansasEl Dorado

Email Frank Bailey Frank Bailey on LinkedIn Frank Bailey on Twitter Frank Bailey on Facebook
Frank Bailey
Frank Bailey
Contributor •

DURAGESIC PATCH RECALL

Comments Off

The Duragesic Fentanyl transdermal system is fatally flawed. There have been thousands of deaths nationwide associated with Fentanyl overdoses from defective patches.

The Duragesic patch is manufactured by two Johnson & Johnson subsidiaries, Janssen Pharmaceutica,L.P. and Alza Corp. The patch was put on the market in 1991. Shortly there were numerous cases of Fentanyl overdosing from the patch.

As early as 2001, the companies knew there was a problem with the manufacturing process. Types of defects that have been found include, foldovers in the backing of the patch system, gel in the seal, seal breaches, corners of the patch system cut off, holes in the drug reservoir, slits in the patch’s pouch and system, air bubbles in the adhesive layers of the system, no gel in the system, and lack of adhesions in the patch system.

In June of 2005, the FDA issued a public health advisory on the Duragesic patch and announced that it was investigating deaths and serious side effects from Fentanyl overdoses related to the patch.

On February 12, 2008, all lots of 25 microgram/hour DURAGESIC CII patches sold by PriCara were recalled. The patches had expiration dates on or before December 2009 and were manufactured by ALZA Corporation.

It is important that drug manufacturers stop putting profit before safety and become accountable for the harm they cause. You can help by alerting your family and friends of this dangerous product. If you have questions concerning DURAGESIC patches we will be glad to provide answers.